Skip to main content

Table 2 Questionnaire Means and Standard Deviations per Treatment Modality Group and Adjusted Standardised Regression Coefficients for Face-to-Face vs. Telepsychiatry Combined

From: Treatment provision for adults with ADHD during the COVID-19 pandemic: an exploratory study on patient and therapist experience with on-site sessions using face masks vs. telepsychiatric sessions

 

Face-to-face

(n = 29)

Videoconferencing

(n = 11)

Telephone

(n = 20)

β

p

SEQ

 depth

5.50 (0.73)

4.47 (1.07)

5.12 (0.89)

−0.49

.001

 smoothness

5.68 (1.02)

5.14 (1.40)

5.49 (1.05)

−0.10

.508

 post-session positivity

5.36 (1.12)

5.35 (1.14)

5.44 (0.98)

0.06

.731

CSQ

 total score

3.75 (0.30)

3.63 (0.38)

3.71 (0.30)

−0.23

.143

WAI-SR-P

 bond

4.41 (0.51)

4.39 (0.60)

4.21 (0.72)

−0.16

.322

 tasks

3.99 (0.52)

3.75 (0.68)

3.78 (0.68)

−0.27

.084

 goals

3.95 (0.58)

4.14 (0.49)

3.93 (0.77)

0.08

.612

WAI-SR-T

 bond

4.16 (0.50)

4.30 (0.33)

4.04 (0.53)

−0.19

.207

 tasks

3.75 (0.45)

3.93 (0.37)

3.61 (0.50)

−0.19

.221

 goals

3.62 (0.47)

3.91 (0.44)

3.53 (0.39)

−0.03

.844

  1. Note: The values represent the mean; the standard deviation is reported in brackets. The maximum scores for the SEQ subscales, the WAI-SR subscales, and the CSQ scale are 7, 5, and 4, respectively. The standardized beta coefficient for the predictor treatment modality (face-to-face or telepsychiatry [telephone and videoconferencing combined]; reference group: face-to-face), which is adjusted for therapist and number of sessions, is reported for each outcome variable together with the p value of the regression coefficient